192 related articles for article (PubMed ID: 19936624)
1. Seizure risk in brain tumor patients with conversion to generic levetiracetam.
Armstrong TS; Choi S; Walker J; Gilbert MR
J Neurooncol; 2010 May; 98(1):137-41. PubMed ID: 19936624
[TBL] [Abstract][Full Text] [Related]
2. Brand name to generic substitution of levetiracetam in patients with epilepsy.
Gha-Hyun L; Dae SJ
Seizure; 2018 Aug; 60():127-131. PubMed ID: 29960217
[TBL] [Abstract][Full Text] [Related]
3. Generic substitution of levetiracetam resulting in increased incidence of breakthrough seizures.
Fitzgerald CL; Jacobson MP
Ann Pharmacother; 2011 May; 45(5):e27. PubMed ID: 21521860
[TBL] [Abstract][Full Text] [Related]
4. Brand-to-generic levetiracetam switch in patients with epilepsy in a routine clinical setting.
Markoula S; Chatzistefanidis D; Gatzonis S; Siatouni A; Siarava E; Verentzioti A; Kyritsis AP; Patsalos PN
Seizure; 2017 May; 48():1-6. PubMed ID: 28363098
[TBL] [Abstract][Full Text] [Related]
5. Clinical experience with generic levetiracetam in people with epilepsy.
Chaluvadi S; Chiang S; Tran L; Goldsmith CE; Friedman DE
Epilepsia; 2011 Apr; 52(4):810-5. PubMed ID: 21426334
[TBL] [Abstract][Full Text] [Related]
6. Impact of generic substitution on levetiracetam serum concentration-A prospective study in an outpatient setting.
Reimers A; Olsson P; Nilsson J; Hoff E; Reis M; Strandberg M; Lundgren A; Källén K
Epilepsy Res; 2017 Aug; 134():54-61. PubMed ID: 28595756
[TBL] [Abstract][Full Text] [Related]
7. Retrospective analysis of the efficacy and tolerability of levetiracetam in patients with metastatic brain tumors.
Newton HB; Dalton J; Goldlust S; Pearl D
J Neurooncol; 2007 Sep; 84(3):293-6. PubMed ID: 17431542
[TBL] [Abstract][Full Text] [Related]
8. Levetiracetam compared with valproic acid for the prevention of postoperative seizures after supratentorial tumor surgery: a retrospective chart review.
Lee YJ; Kim T; Bae SH; Kim YH; Han JH; Yun CH; Kim CY
CNS Drugs; 2013 Sep; 27(9):753-9. PubMed ID: 23921717
[TBL] [Abstract][Full Text] [Related]
9. Safety of Overnight Switch from Brand-Name to Generic Levetiracetam.
Vari MS; Pinto F; Mencaroni E; Giudizioso G; Minetti C; La Neve A; Francavilla T; Piccioli M; Striano S; del Gaudio L; Tovo P; Striano P; Verrotti A
Clin Drug Investig; 2016 Jan; 36(1):87-91. PubMed ID: 26507620
[TBL] [Abstract][Full Text] [Related]
10. Levetiracetam for seizure prevention in brain tumor patients: a systematic review.
Nasr ZG; Paravattil B; Wilby KJ
J Neurooncol; 2016 Aug; 129(1):1-13. PubMed ID: 27168191
[TBL] [Abstract][Full Text] [Related]
11. [Effect of levetiracetam on intractable secondarily generalized seizure and depression].
Hayashi T; Inoue K; Shinoda J
Brain Nerve; 2012 Mar; 64(3):303-7. PubMed ID: 22402725
[TBL] [Abstract][Full Text] [Related]
12. Seizures in patients with glioma treated with phenytoin and levetiracetam.
Merrell RT; Anderson SK; Meyer FB; Lachance DH
J Neurosurg; 2010 Dec; 113(6):1176-81. PubMed ID: 20560728
[TBL] [Abstract][Full Text] [Related]
13. Quality of life and seizure control in patients with brain tumor-related epilepsy treated with levetiracetam monotherapy: preliminary data of an open-label study.
Dinapoli L; Maschio M; Jandolo B; Fabi A; Pace A; Sperati F; Muti P
Neurol Sci; 2009 Aug; 30(4):353-9. PubMed ID: 19415165
[TBL] [Abstract][Full Text] [Related]
14. Quality of life after switching to generic levetiracetam - A prospective comparative study.
Olsson P; Reimers A; Källén K
Epilepsy Behav; 2019 Jul; 96():169-174. PubMed ID: 31150996
[TBL] [Abstract][Full Text] [Related]
15. Remember Keppra: seizure control with subcutaneous levetiracetam infusion.
Murray-Brown FL; Stewart A
BMJ Support Palliat Care; 2016 Mar; 6(1):12-3. PubMed ID: 26811092
[No Abstract] [Full Text] [Related]
16. Safety and feasibility of switching from phenytoin to levetiracetam monotherapy for glioma-related seizure control following craniotomy: a randomized phase II pilot study.
Lim DA; Tarapore P; Chang E; Burt M; Chakalian L; Barbaro N; Chang S; Lamborn KR; McDermott MW
J Neurooncol; 2009 Jul; 93(3):349-54. PubMed ID: 19169651
[TBL] [Abstract][Full Text] [Related]
17. Antiepileptic drugs for treating seizures in adults with brain tumours.
Kerrigan S; Grant R
Cochrane Database Syst Rev; 2011 Aug; 2011(8):CD008586. PubMed ID: 21833969
[TBL] [Abstract][Full Text] [Related]
18. A prospective evaluation and literature review of levetiracetam use in patients with brain tumors and seizures.
Usery JB; Michael LM; Sills AK; Finch CK
J Neurooncol; 2010 Sep; 99(2):251-60. PubMed ID: 20146087
[TBL] [Abstract][Full Text] [Related]
19. Retrospective analysis of the efficacy and tolerability of levetiracetam in brain tumor patients.
Newton HB; Goldlust SA; Pearl D
J Neurooncol; 2006 May; 78(1):99-102. PubMed ID: 16541329
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of anti-epileptic drugs in patients with gliomas and seizures.
van Breemen MS; Rijsman RM; Taphoorn MJ; Walchenbach R; Zwinkels H; Vecht CJ
J Neurol; 2009 Sep; 256(9):1519-26. PubMed ID: 19434440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
